PB2186 IMPACT OF CYTOGENETIC ABNORMALITIES ON RESPONSE IN A COHORT OF INDIAN MULTIPLE MYELOMA PATIENTS–IS 13Q DELETION THE NEW 17P IN DISGUISE?

Authors :: T. Seth
R. Saxena
R. Halder
Rishi Dhawan
S. P. Mirgh
Mukul Aggarwal
M. Mahapatra
S. Tyagi
S. Kothari
H.P. Pati
Source :: HemaSphere. 3:981
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Cohort
medicine
Hematology
business
medicine.disease
Multiple myeloma

Full Text Access

Tools